Following a request from the European Commission, the Panel on Additives and Products or Substances used in Animal Feed (FEEDAP) was asked to deliver a scientific opinion onL-tryptophan produced by fermentation with a non-genetically modified strain of Escherichia coli KCCM 10534 when used as a nutritional additive in feed and water for drinking for all animal species and categories. The production strain E. coli KCCM 10534 is safe for the production ofL-tryptophan and it was not detected in the final product. The use ofL-tryptophan produced using E. coli KCCM 10534 in supplementing feed to compensate for tryptophan deficiency in feedingstuffs is safe for non-ruminant target species. There may be a risk for an increased production of toxic metabolites when unprotected tryptophan is used in ruminants. The FEEDAP Panel has concerns on the safety of the simultaneous oral administration ofL-tryptophan via water for drinking and feed due to possible amino acid imbalances. The use ofL-Tryptophan produced by E. coli KCCM 10534 in animal nutrition raises no safety concerns to consumers of animal products and to the environment. The additive under assessment is considered not toxic by inhalation, it is not a skin or eye irritant and is not a skin sensitiser. The endotoxin activity of the additive and its dusting potential indicate a risk by inhalation for the users. The productL-tryptophan is regarded as an effective source of the amino acidL-tryptophan for all non-ruminant species. In order to be as efficacious in ruminants as in non-ruminants, it should be protected from ruminal degradation.

Safety and efficacy of L-tryptophan produced by fermentation with Escherichia coli KCCM 10534 for all animal species / V. Bampidis, G. Azimonti, M.L. Bastos, H. Christensen, B. Dusemund, M.K. Durjava, M. Kouba, M. Lopez-Alonso, S.L. Puente, F. Marcon, B. Mayo, A. Pechova, M. Petkova, Y. Sanz, R.E. Villa, R. Woutersen, F. Cubadda, N. Dierick, B. Glandorf, L. Herman, A. Mantovani, M. Saarela, M. Anguita, E. Pettenati, J. Tarres-Call, F. Ramos. - In: EFSA JOURNAL. - ISSN 1831-4732. - 18:4(2020 Apr), pp. 6071.1-6071.18. [10.2903/j.efsa.2020.6071]

Safety and efficacy of L-tryptophan produced by fermentation with Escherichia coli KCCM 10534 for all animal species

R.E. Villa;
2020

Abstract

Following a request from the European Commission, the Panel on Additives and Products or Substances used in Animal Feed (FEEDAP) was asked to deliver a scientific opinion onL-tryptophan produced by fermentation with a non-genetically modified strain of Escherichia coli KCCM 10534 when used as a nutritional additive in feed and water for drinking for all animal species and categories. The production strain E. coli KCCM 10534 is safe for the production ofL-tryptophan and it was not detected in the final product. The use ofL-tryptophan produced using E. coli KCCM 10534 in supplementing feed to compensate for tryptophan deficiency in feedingstuffs is safe for non-ruminant target species. There may be a risk for an increased production of toxic metabolites when unprotected tryptophan is used in ruminants. The FEEDAP Panel has concerns on the safety of the simultaneous oral administration ofL-tryptophan via water for drinking and feed due to possible amino acid imbalances. The use ofL-Tryptophan produced by E. coli KCCM 10534 in animal nutrition raises no safety concerns to consumers of animal products and to the environment. The additive under assessment is considered not toxic by inhalation, it is not a skin or eye irritant and is not a skin sensitiser. The endotoxin activity of the additive and its dusting potential indicate a risk by inhalation for the users. The productL-tryptophan is regarded as an effective source of the amino acidL-tryptophan for all non-ruminant species. In order to be as efficacious in ruminants as in non-ruminants, it should be protected from ruminal degradation.
L; -tryptophan; Amino acid; Efficacy; Escherichia coli; Nutritional additive; Safety;
Settore VET/07 - Farmacologia e Tossicologia Veterinaria
Article (author)
File in questo prodotto:
File Dimensione Formato  
j.efsa.2020.6071.pdf

accesso aperto

Tipologia: Publisher's version/PDF
Dimensione 1.97 MB
Formato Adobe PDF
1.97 MB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/828582
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 1
social impact